Bovie Presentation

This presentation may contain some forward looking statements, particularly regarding operational prospects in 2008 and beyond, which involve a number of risks and uncertainties that could cause actual results to differ materially. These risks are listed from time to time in the Company’s SEC filings.

BOVIE = ELECTROSURGERY

Surgical instruments in the OR that are related to electrosurgery are called by the name “BOVIE.”

Branding the “Bovie” name within the medical community

Over 32 million surgical procedures in U.S.

Bovie Medical

ICON Generators

TissueResection

ICON GP/VS

CanadayAccessories

Icon GS Plasma

MEG LineInstruments

BovieElectrosurgery

High & Low Temperature Cauteries

Targeted towards the Gastroenterology market.

Over $150 million market including accessories growing 7-9% per year

13,000 operating centers Icon platform provides the basis

to develop customized generators for other specialties (ex. Oncology $200 million).

MEG line of instruments

MEG/Polaris™ Instruments The only product that can compete in three

markets and address all areas of minimally invasive surgeries:

Arthroscopy Instrument Market $200 million Laparoscopy Instrument Market $300 million

Vessel Sealing Market $500 million

Arthroscopy Instrument Market research indicates little to no

innovation from top five companies in this space over the past 15 years.

The only modular arthroscopy instrument available.

Can dramatically reduce cost to the end user.

The only arthroscopy instrument with a flushing port for cleaning.

One tip design can replace multiple instruments.

Laparoscopy Instrument Handle accepts inserts from 2mm

to 12mm Cancelable ratchet feature can be

activated either left or right handed.

Ergonomic handle reduces fatigue and creates more leverage.

Modular design can significantly reduce cost

Metallic handle is electrically isolated to increase instrument life.

Vessel Sealing Instrument Only modular designed laparoscopic VS instrument Handle can accommodate both “open” and laparoscopic

instrument tips. “Seal and Cut” design. Can be used with existing vessel sealing generators or

user can gain enhanced benefits with Bovie generator. Significantly reduces costs. Largest (total market size $500 million) and fastest

growing (10-15%) segment with highest margins.

•Ergonomic •360 Rotation of cartridge•Electrode quick attachment-detachment•Can be controlled by three triggers:

Jaw triggerCoagulation + sealing triggerPowered blade trigger

Handle & Bovie VS generator provides:

•Cartridge recognition and initial setup•Automatic bipolar cut upon blade advancement•Modulated vessel sealing automatic cycles•Minimal charring and adhesion

Suitable for a variety of endoscopic Bipolar AND Monopolar or Inert applications like

Vessel SealingLaparoscopyEndo GYN

ArthroscopyUrology

Thoracic EndoscopySinoscopy

and many other open surgery adaptations

Tissue Resection Device

Delivers RF current & sterile saline for resection, hemostatic sealing and coagulation

Lowers blood loss, procedure times and cost savings for hospitals

Liver, pancreatic, kidney tumor removal Orthopedic and laparoscopic surgeries Worldwide market size in 2009 approx. $500 million

ICON GS Plasma System

J-Plasma is formed by holding a sharp conductive point at High Voltage and High Frequency, over which an Inert Gas, such as Helium, flows.

ICON GS Plasma System

Produces a stable thin focused beam of ionized helium gas

Provides minimal invasiveness and precision

No conductive currents during surgery One working electrode

Canady Technology Agreements

Worldwide distribution and manufacturing agreement for Canady’s plasma related devices and accessories.

Canady Technology will assist in the clinical development of Bovie’s J-Plasma technology.

Canady Technology was the first to demonstrate the utilization of tissue coagulation by argon plasma coagulation via flexible endoscopes.

Bovie Medical Financials

Amex Symbol: BVX Fiscal year 2007 revenues rose to a

record $28.78 million. Net income for fiscal 2007 was

$2,400,591 or $.14 per diluted EPS. 17,600,000 diluted shares outstanding. 10% insider ownership.

Contact Information

Bovie Medical, Inc. Suite 207, 734 Walt Whitman Road

Melville, NY 11747 800-888-4999

boviemed@aol.com

Buttonwood Advisory Group, Inc. 15705 Framingham Lane Huntersville, NC 28078

800-940-9087janeralla@bellsouth.net